{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:24:30Z","timestamp":1777627470658,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2012\/22514-3"],"award-info":[{"award-number":["2012\/22514-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.cyto.2018.07.017","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T23:53:52Z","timestamp":1532130832000},"page":"285-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Therapeutic effects of vaccine derived from amastigote surface protein-2 (ASP-2) against Chagas disease in mouse liver"],"prefix":"10.1016","volume":"113","author":[{"given":"Fl\u00e1via Andressa Pidone","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila","family":"Pontes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo T.","family":"Gazzinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar-Bruna","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana Cruz","family":"Lazzarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Fontes","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1via","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Pellegrini","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ronnie Carvalho","family":"de Vasconcelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Araki","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2018.07.017_b0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.idc.2012.03.002","article-title":"American trypanosomiasis (Chagas disease)","volume":"26","author":"Rassi","year":"2012","journal-title":"Infectious Dis. Clinics North America"},{"issue":"1","key":"10.1016\/j.cyto.2018.07.017_b0010","doi-asserted-by":"crossref","first-page":"e1965","DOI":"10.1371\/journal.pntd.0001965","article-title":"Immunosuppression and Chagas disease: a management challenge","volume":"7","author":"Pinazo","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.cyto.2018.07.017_b0015","first-page":"19","article-title":"Toxic effects of nifurtimox and benznidazole, two drugs used against American trypanosomiasis (Chagas' disease)","volume":"1","author":"Castro","year":"1988","journal-title":"Biomed. Environ. Sci."},{"issue":"2","key":"10.1016\/j.cyto.2018.07.017_b0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1515\/cclm-2012-0316","article-title":"Chronic Chagas disease: from basics to laboratory medicine","volume":"51","author":"Haberland","year":"2013","journal-title":"Clin. Chem. Lab Med."},{"issue":"6","key":"10.1016\/j.cyto.2018.07.017_b0025","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/eji.200324660","article-title":"AgC10, a mucin from Trypanosoma cruzi, destabilizes TNF and cyclooxygenase-2 mRNA by inhibiting mitogen-activated protein kinase p38","volume":"34","author":"Alcaide","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2018.07.017_b0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.vph.2016.03.002","article-title":"Mechanisms of vascular dysfunction in acute phase of Trypanosoma cruzi infection in mice","volume":"82","author":"Silva","year":"2016","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.cyto.2018.07.017_b0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bbi.2017.05.017","article-title":"Death of adrenocortical cells during murine acute T. cruzi infection is not associated with TNF-R1 signaling but mostly with the type II pathway of Fas-mediated apoptosis","volume":"65","author":"P\u00e9rez","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cyto.2018.07.017_b0040","doi-asserted-by":"crossref","first-page":"e0003464","DOI":"10.1371\/journal.pntd.0003464","article-title":"Trypanosoma cruzi infection is a potent risk factor for nonalcoholic steatohepatitis enhancing local and systemic inflammation associated with strong oxidative stress and metabolic disorders","volume":"9","author":"Onofrio","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cyto.2018.07.017_b0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.exppara.2016.09.015","article-title":"Hepatic injury associated with Trypanosoma cruzi infection is attenuated by treatment with 15-deoxy-\u0394(12,14) prostaglandin J(2)","volume":"170","author":"Penas","year":"2016","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cyto.2018.07.017_b0050","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1371\/journal.pntd.0000578","article-title":"The liver plays a major role in clearance and destruction of blood trypomastigotes in Trypanosoma cruzi chronically infected mice","volume":"4","author":"Sardinha","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cyto.2018.07.017_b0055","doi-asserted-by":"crossref","first-page":"930e935","DOI":"10.1002\/eji.1830141013","article-title":"Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro","volume":"14","author":"Plata","year":"1984","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2018.07.017_b0060","doi-asserted-by":"crossref","first-page":"e863","DOI":"10.1371\/journal.pntd.0000863","article-title":"Importance of TLR2 on hepatic immune and non-immune cells to attenuate the strong inflammatory liver response during Trypanosoma cruzi acute infection","volume":"4","author":"Carrera-Silva","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"9","key":"10.1016\/j.cyto.2018.07.017_b0065","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1089\/hum.2004.15.878","article-title":"Protective immunity against Trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase","volume":"15","author":"Vasconcelos","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.cyto.2018.07.017_b0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/B978-0-12-385863-4.00006-X","article-title":"Vaccine development against Trypanosoma cruzi and Chagas disease","volume":"75","author":"V\u00e1zquez-Chagoy\u00e1n","year":"2011","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.cyto.2018.07.017_b0075","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.meegid.2009.02.009","article-title":"Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era","volume":"9","author":"Dumonteil","year":"2009","journal-title":"Inf. Genet. Evol."},{"key":"10.1016\/j.cyto.2018.07.017_b0080","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4161\/hv.7.11.17016","article-title":"Advances and challenges towards a vaccine against Chagas disease","volume":"7","author":"Quijano-Hernandez","year":"2011","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.cyto.2018.07.017_b0085","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev.mi.48.100194.002435","article-title":"Structural and functional properties of Trypanosoma trans-sialidase","volume":"48","author":"Schenkman","year":"1994","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.cyto.2018.07.017_b0090","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1172\/JCI3835","article-title":"Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses","volume":"102","author":"Wizel","year":"1998","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.cyto.2018.07.017_b0095","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4049\/jimmunol.143.3.1001","article-title":"Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies. Purification and molecular characterization of an 83-kilodalton amastigote protein","volume":"143","author":"Pan","year":"1989","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2018.07.017_b0100","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1128\/IAI.71.5.2744-2757.2003","article-title":"Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection","volume":"71","author":"Boscardin","year":"2003","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.cyto.2018.07.017_b0105","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1128\/IAI.70.10.5547-5555.2002","article-title":"Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection","volume":"70","author":"Garg","year":"2002","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.cyto.2018.07.017_b0110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1586\/14760584.6.2.255","article-title":"Use of viral vectors for the development of vaccines","volume":"6","author":"Liniger","year":"2007","journal-title":"Expert. Rev. Vaccines."},{"issue":"9","key":"10.1016\/j.cyto.2018.07.017_b0115","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1089\/hum.2006.17.898","article-title":"Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase","volume":"17","author":"Machado","year":"2006","journal-title":"Hum. Gene. Ther."},{"issue":"4","key":"10.1016\/j.cyto.2018.07.017_b0120","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1371\/journal.pone.0000393","article-title":"Modulation of CD4(+) T cell-dependent specific cytotoxic CD8(+) T cells differentiation and proliferation by the timing of increase in the pathogen load","volume":"2","author":"Tzelepis","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2018.07.017_b0125","doi-asserted-by":"crossref","first-page":"605023","DOI":"10.1155\/2014\/605023","article-title":"Genetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi","volume":"2014","author":"Ara\u00fajo","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"5","key":"10.1016\/j.cyto.2018.07.017_b0130","doi-asserted-by":"crossref","first-page":"e1002699","DOI":"10.1371\/journal.ppat.1002699","article-title":"Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine","volume":"8","author":"Vasconcelos","year":"2012","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.cyto.2018.07.017_b0135","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF01002772","article-title":"Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections","volume":"11","author":"Junqueira","year":"1979","journal-title":"Histochem. J."},{"issue":"2","key":"10.1016\/j.cyto.2018.07.017_b0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1590\/0074-02760140311","article-title":"Role Of cyclooxygenase-2 In Trypanosoma cruzi survival in the early stages of parasite host-cell interaction","volume":"110","author":"Moraes","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz."},{"key":"10.1016\/j.cyto.2018.07.017_b0145","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/expr.1996.0109","article-title":"Trypanosoma cruzi: IL-10, TNF, IFN-c and IL-12 regulate innate and acquired immunity to infection","volume":"84","author":"Abrahamsohn","year":"1996","journal-title":"Exp. Parasiol."},{"key":"10.1016\/j.cyto.2018.07.017_b0150","first-page":"683230","article-title":"Chagas disease cardiomyopathy: immunopathology and genetics","author":"Cunha-Neto","year":"2014","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cyto.2018.07.017_b0155","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/iai.64.6.1961-1967.1996","article-title":"Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes","volume":"64","author":"Aliberti","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cyto.2018.07.017_b0160","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1128\/IAI.67.9.4819-4826.1999","article-title":"Chemokines enhance parasite uptake and promote nitric oxide dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi","volume":"67","author":"Aliberti","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cyto.2018.07.017_b0165","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1128\/IAI.66.3.1208-1215.1998","article-title":"Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase","volume":"66","author":"Holscher","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cyto.2018.07.017_b0170","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nri1978","article-title":"Protozoan encounters with toll like receptor signalling pathways: implications for host parasitism","volume":"6","author":"Gazzinelli","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2018.07.017_b0175","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.2217\/fmb.11.122","article-title":"The role of toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan","volume":"6","author":"Pellegrini","year":"2011","journal-title":"Future Microbiol."},{"issue":"1","key":"10.1016\/j.cyto.2018.07.017_b0180","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000443238","article-title":"Decreased toll-like receptor 2 and toll-like receptor 7\/8-induced cytokines in Parkinson's disease patients","volume":"23","author":"da Silva","year":"2016","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.cyto.2018.07.017_b0185","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2650621","article-title":"Interleukin-6 and the acute phase response","volume":"265","author":"Heinrich","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.cyto.2018.07.017_b0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","article-title":"Interleukin-10-deficient mice develop chronic enterocolitis","volume":"75","author":"Kuhn","year":"1993","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.cyto.2018.07.017_b0195","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","article-title":"Biology of interleukin-10","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2018.07.017_b0200","first-page":"2","article-title":"Twenty-five years of studies in trials for the therapeutic application of IL 10 immunomodulating properties. From high doses administration to low dose medicine new paradigm","volume":"1","author":"Fioranelli","year":"2014","journal-title":"J. Integr. Cardiol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618303090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618303090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:51:29Z","timestamp":1760907089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466618303090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":40,"alternative-id":["S1043466618303090"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2018.07.017","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effects of vaccine derived from amastigote surface protein-2 (ASP-2) against Chagas disease in mouse liver","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2018.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}